Vernal Biosciences picks up $21m

Vernal Biosciences, a technology-leading mRNA manufacturer and formulator of LNP-mRNA, has closed $21 million in financing.

3 June 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Healthcare Briefs